Trial in Progress: Real-World Safety and Effectiveness of Brentuximab Vedotin in Adults with CD30+ Lymphoma in China by Xu, Pengpeng, Cai, Mingci, Zhang, Wendy, Zhao, Wei Li

Get full text

Selinexor in Combination with Salvage Regimen for Refractory Peripheral T-Cell Lymphoma (PTCL) Patients by Wang, Li, CAI, Mingci, Huang, Yaohui, Xu, Pengpeng, Chen, Shu, Zhao, Weili

Get full text

Up‐front autologous stem cell transplant in peripheral T‐cell lymphoma patients achieving complete response after first‐line treatment: A multicentre real‐world analysis by Yang, Peipei, Cai, Mingci, Cao, Yang, Fan, Shuang, Tang, Wei, Ji, Mengmeng, Huang, Liang, Wang, Fengrong, Zhao, Weili, Niu, Ting, Mo, Xiaodong

Get full text

The genetic landscape of histologically transformed marginal zone lymphomas by Li, Anqi, Yi, Hongmei, Deng, Shijie, Ruan, Miao, Xu, Pengpeng, Huo, Yujia, Lu, Haiyang, Shen, Xia, Ouyang, Binsen, Cai, Mingci, Xu, Haimin, Wang, Zhongyu, Zhang, Lei, Zhu, Lingyan, Peng, Qi, Gu, Yijin, Xie, Jialing, Wang, Yan, Dong, Lei, Liu, Zebing, Wang, Chaofu

Get full text

CEOP/IVE/GDP Alternating Regimen Compared with CEOP As the First-Line Therapy for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma: Results from a Phase 2, Multi-Center, Ra... by Cai, Mingci, Cheng, Shu, Xin, Wang, Hu, Jianda, Song, Yongping, Yan, Zixun, Jiang, Yujie, Fang, Xiaosheng, Zheng, Xiaoyun, Dong, Lihua, Ji, Mengmeng, Wang, Li, Xu, Pengpeng, Zhao, Weili

Get full text